Screener
Vertex Pharmaceuticals VRTX Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's net debt?
- Vertex Pharmaceuticals (VRTX) reported net debt of -$5.87B in Q2 2026.
- How has Vertex Pharmaceuticals's net debt changed year-over-year?
- Vertex Pharmaceuticals's net debt decreased by 70.1% year-over-year, from -$3.45B to -$5.87B.
- What is the long-term trend for Vertex Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's net debt has grown at a 10.4% compound annual growth rate (CAGR), from -$1.86B to -$3.05B.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Vertex Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude